John Irving Bell - May 23, 2024 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
Director
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Stock symbol
IMCR
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/28/2024, 04:15 PM
Previous filing
Jan 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Share Option (Right to Buy) Award $0 +14.5K $0.00 14.5K May 23, 2024 Ordinary Shares 14.5K $50.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option award shall vest at the earlier of (i) May 23, 2025 and (ii) the day immediately prior to the date of our next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.